Volume 58, Issue 4, Pages (October 2000)

Slides:



Advertisements
Similar presentations
Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure  William C. Wolf, Hideaki.
Advertisements

Volume 61, Issue 4, Pages (April 2002)
Lymphatic vessels develop during tubulointerstitial fibrosis
Volume 66, Issue 4, Pages (October 2004)
Volume 72, Issue 10, Pages (November 2007)
Histology Quiz: The Urinary System By Andrew W
Urea channel inhibitors: a new functional class of aquaretics
Volume 76, Issue 7, Pages (October 2009)
Volume 81, Issue 9, Pages (May 2012)
Volume 62, Issue 6, Pages (December 2002)
Volume 55, Issue 4, Pages (April 1999)
AJKD Atlas of Renal Pathology: Chronic Antibody-Mediated Rejection
Volume 61, Issue 2, (February 2002)
Volume 54, Issue 2, Pages (August 1998)
Volume 81, Issue 9, Pages (May 2012)
Volume 61, Issue 3, Pages (March 2002)
Volume 60, Issue 3, Pages (September 2001)
Volume 62, Issue 1, Pages (July 2002)
Serine 269 phosphorylated aquaporin-2 is targeted to the apical membrane of collecting duct principal cells  Hanne B. Moeller, Mark A. Knepper, Robert.
A new mouse model of immune-mediated podocyte injury
Volume 58, Issue 5, Pages (November 2000)
Hiroyuki Yanagisawa, Nobuyuki Yamazaki, Gen Sato, Osamu Wada 
Volume 67, Issue 6, Pages (June 2005)
Volume 66, Issue 1, Pages (July 2004)
Volume 54, Issue 5, Pages (November 1998)
Volume 63, Issue 5, Pages (May 2003)
Urea channel inhibitors: a new functional class of aquaretics
Volume 61, Issue 2, Pages (February 2002)
The missing medullary sponge kidney
C3 glomerulopathy: what's in a name?
Volume 57, Issue 5, Pages (May 2000)
Proinflammatory effects of iron sucrose in chronic kidney disease
Volume 63, Issue 2, Pages (February 2003)
A novel model to study renal myofibroblast formation in vitro
Volume 60, Issue 6, Pages (December 2001)
Volume 56, Issue 3, Pages (September 1999)
Volume 62, Issue 2, Pages (August 2002)
Volume 54, Issue 2, Pages (August 1998)
Volume 67, Issue 2, Pages (February 2005)
Lymphatic vessels develop during tubulointerstitial fibrosis
Volume 66, Issue 3, Pages (September 2004)
Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure  William C. Wolf, Hideaki.
Volume 73, Issue 12, Pages (June 2008)
Akira Shimizu, Kazuhiko Yamada, David H. Sachs, Robert B. Colvin 
Volume 53, Issue 5, Pages (May 1998)
Volume 56, Issue 3, Pages (September 1999)
Volume 61, Issue 4, Pages (April 2002)
Volume 58, Issue 6, Pages (December 2000)
Volume 67, Issue 2, Pages (February 2005)
C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis  Gopala K. Rangan, Jeffrey W. Pippin, William.
Volume 56, Issue 6, Pages (December 1999)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Distribution of postsynaptic density proteins in rat kidney: Relationship to neuronal nitric oxide synthase  Akihiro Tojo, David S. Bredt, Christopher.
Immunolocalization of phospholipase C isoforms in rat kidney
Volume 60, Issue 5, Pages (November 2001)
Aquaporins in the kidney: Emerging new aspects
Endothelial cell activation
Volume 62, Issue 3, Pages (September 2002)
Inflammatory cells in ischemic acute renal failure
N. Maril, R. Margalit, S. Rosen, S.N. Heyman, H. Degani 
Volume 72, Issue 4, Pages (August 2007)
AKAP220 colocalizes with AQP2 in the inner medullary collecting ducts
M.J. Butt, A.F. Tarantal, D.F. Jimenez, D.G. Matsell 
Volume 62, Issue 5, (November 2002)
Volume 76, Issue 9, Pages (November 2009)
T-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis  Masashi Haraguchi, Wayne A. Border, Yufeng Huang,
A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia–reperfusion injury  L.-W. Lai, K.-C. Yong,
Volume 74, Issue 8, Pages (October 2008)
Volume 56, Issue 6, Pages (December 1999)
Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease  T.A.O. Jiang,
Presentation transcript:

Volume 58, Issue 4, Pages 1569-1579 (October 2000) CD59 protects rat kidney from complement mediated injury in collaboration with Crry  Midoriko Watanabe, Yoshiki Morita, Masashi Mizuno, Kazuhiro Nishikawa, Yukio Yuzawa, Nigishi Hotta, B. Paul Morgan, Noriko Okada, Hidechika Okada, Seiichi Matsuo  Kidney International  Volume 58, Issue 4, Pages 1569-1579 (October 2000) DOI: 10.1046/j.1523-1755.2000.00318.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 Light microscopy at day 4 in groups I and II (A and B) cortex, (C and D) outer medulla, and (E and F) inner medulla. Tubular dilation and cast formation are seen in rat of both groups, but these changes are more prominent in group II. In the outer medulla, the structure of vasa recta is not clear in group II (Group I, PAS, ×200, A, C, and E); Group II, B, D, and F). Kidney International 2000 58, 1569-1579DOI: (10.1046/j.1523-1755.2000.00318.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 2 Light microscopy at day 7 in groups I and II (A and B) cortex, (C and D) outer medulla, and (E and F) inner medulla. Tubular dilation and cast formation are still present in group II, while these changes are almost healed in group I (Group I, PAS, ×200, A, C, and E; Group II, B, D and F). Kidney International 2000 58, 1569-1579DOI: (10.1046/j.1523-1755.2000.00318.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 3 Semiquantitative analysis of tubular changes by light microscopy. Note that the changes are most prominent in group II and that the tubular changes are still prominent at day 7. Symbols are: (▪) group I; () group II, (□) group III; () group IV; () group V; *P < 0.01 group II vs. other groups; **P < 0.01 groups I or III vs. groups IV or V; #P < 0.01 groups I or II or III vs. group IV or V; no significant difference among groups I, II, and III. Kidney International 2000 58, 1569-1579DOI: (10.1046/j.1523-1755.2000.00318.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 4 Semiquantitative analysis of deposition of C3 and MAC in the kidney by immunofluorescence miscroscopy. Note that deposition of C3 is comparable among groups I, II, and III, while MAC deposition is most prominent in group II. Symbols are: (▪) group I; () group II, (□) group III; () group IV; () group V; #P < 0.01, there is no significant difference among groups I, II, and III. *P < 0.01 group II vs. other groups; **P < 0.01 group I or III vs. group IV or V. Kidney International 2000 58, 1569-1579DOI: (10.1046/j.1523-1755.2000.00318.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 5 Immunofluorescence showing deposition of MAC at day 4 in (A and B) cortex, (C and D) outer medulla, and (E and F) inner medulla. Circumferential binding of MAC was observed along cortical tubular basement membranes (arrow heads) in both groups, whereas deposition is also detected in peritubular capillaries (arrows), vasa recta (VR), and the medullary capillaries in group II. Staining in these area of group I rats is faint. C, collecting duct (Group I, ×200, A, C, and E; Group II, B, D, and F). Kidney International 2000 58, 1569-1579DOI: (10.1046/j.1523-1755.2000.00318.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 6 Quantitative analysis of leukocyte infiltration in the tubulointerstitium. Note that infiltration of LCA-positive leukocytes is most prominent in group II at day 4 and day 7. Symbols are: (▪) group I; () group II, (□) group III; () group IV; () group V; *P < 0.01 group II vs. other groups; **P < 0.01 groups I or III vs. groups IV or V. Kidney International 2000 58, 1569-1579DOI: (10.1046/j.1523-1755.2000.00318.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 7 Urinary protein excretion. Urinary protein excretion was transiently increased at day 1 in all groups. Note that rats of group II (•) showed significantly higher protein excretion than other groups throughout the time course. In groups I (○), III (▵), IV (□), and V (▪), urinary protein excretion returns to the normal level by day 3. *P < 0.01 group II vs. other groups. Kidney International 2000 58, 1569-1579DOI: (10.1046/j.1523-1755.2000.00318.x) Copyright © 2000 International Society of Nephrology Terms and Conditions